Cerity Partners
NMTR

Cerity Partners’s 9 Meters Biopharma NMTR Stock Holding History

Cerity Partners’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,708
Closed -$7.2K – 1764
2023
Q2 		$7.2K Hold
10,708
– – ﹤0.01% 1616
2023
Q1 		$14.9K Buy
+10,708
New +$20.2K ﹤0.01% 1827

Other funds holding NMTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SIS
Strategic Investment Solutions Orland Park, Illinois $437M AUM 30.41% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
RFA
Register Financial Advisors Atlanta, Georgia $326M AUM 48.38% 1-Year Est. Return

Cerity Partners's NMTR Position: Q3 2023 in Review

Cerity Partners sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 10,708 shares — an estimated $7.2K sold.

Cerity Partners first reported a position in NMTR in Q1 2023 and held it in 2 quarters. The position peaked at $14.9K in Q1 2023. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.

  • Cerity Partners reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
  • Cerity Partners sold 10,708 9 Meters Biopharma shares in Q3 2023, an estimated $7.2K.
  • Cerity Partners first reported a position in 9 Meters Biopharma in Q1 2023 and held it in 2 quarters.
  • Cerity Partners's 9 Meters Biopharma position peaked at $14.9K in Q1 2023.
  • 6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.

Based on Cerity Partners's 13F filing for Q3 2023, filed 14 Nov 2023.